Invasive mucormycosis affecting maxillofacial region in oncohematological patients undergoing chemotherapeutic treatment and transplantation of hematopoietic stem cells

Baranova I.B.; Popova M.O.; Yaremenko A.I.; Zubkova N.V.; Pinegina O.N.; Nikolaev I.Y.

doi:https://doi.org/10.17116/stomat202210102180

Baranova I.B.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

ORCID: 0000-0001-5899-7577

Popova M.O.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Yaremenko A.I.

I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation

Zubkova N.V.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Pinegina O.N.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Nikolaev I.Y.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Invasive mucormycosis affecting maxillofacial region in oncohematological patients undergoing chemotherapeutic treatment and transplantation of hematopoietic stem cells

Authors:

Baranova I.B., Popova M.O., Yaremenko A.I., Zubkova N.V., Pinegina O.N., Nikolaev I.Y.

More about the authors

Journal: Stomatology. 2022;101(2): 80‑86

DOI: 10.17116/stomat202210102180

Read: 2425 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Baranova IB, Popova MO, Yaremenko AI, Zubkova NV, Pinegina ON, Nikolaev IY. Invasive mucormycosis affecting maxillofacial region in oncohematological patients undergoing chemotherapeutic treatment and transplantation of hematopoietic stem cells. Stomatology. 2022;101(2):80‑86. (In Russ.)
https://doi.org/10.17116/stomat202210102180

Подписка 2026 Стоматология (Stomatology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Left ventricular myocardial performance index (Tei index) as an early marker of cardiotoxicity in antitumor therapy. Russian Cardiology Bulletin. 2024;(4-2):137-143

Use of HIFU therapy in combination with monochemotherapy in a patient with locally advanced adenogenic pancreatic cancer and impaired functional status. P.A. Herzen Journal of Oncology. 2025;(3):83-88

Evaluation of the skeletal muscle index in predicting toxic complications of antitumor drug therapy in patients with gastric cancer. P.A. Herzen Journal of Oncology. 2025;(4):29-36

Small cell carcinoma of the parotid gland. P.A. Herzen Journal of Oncology. 2025;(4):69-74

Results of testing an antioxidant gel film for the prevention and treatment of palmar-plantar syndrome in cancer patients. P.A. Herzen Journal of Oncology. 2025;(5):59-63

Predictors of arrhythmia and adverse outcomes in cancer patients during antitumor treatment. Russian Journal of Preventive Medicine. 2025;(11):86-93

Abstract:

The aim of the work is to attract the attention of specialists: dentists, oncologists, hematologists to thorough sanitation of the oral cavity of patients preparing for chemotherapy treatment, to transplantation of hematopoietic stem cells. Two clinical cases described in the article were observed at the R.M. Gorbacheva First Saint-Petersburg State Medical University from 2010 to 2019. They confirm the possibility of the occurrence of infectious complications with damage to the maxillofacial region caused by rare pathogens of invasive mycosis, which debuted as an odontogenic inflammatory process. The success of the treatment of Invasive Mycosis depends on early diagnosis and antimycotic therapy; active surgical tactics in relation to the affected tissues in a controlled course of the underlying disease and the restoration of effective hematopoiesis.

Keywords:

osteomyelitis of the jaws

mucormycosis

oncohematological patients

chemotherapy

hematopoietic stem cell transplantation

Authors:

Baranova I.B.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

ORCID: 0000-0001-5899-7577

Popova M.O.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Yaremenko A.I.

I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation

Zubkova N.V.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Pinegina O.N.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Nikolaev I.Y.

I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation

Received:

10.11.2021

Accepted:

15.12.2021

Close metadata

References:

Afanas’ev BV, Zubarovskaya LS, Semenova EV. Opyt primeneniya nerodstvennoj allogennoj transplantacii stvolovyh gemopoeticheskih kletok v klinike transplantacii kostnogo mozga SPbGMU im. akad. I.P. Pavlova. Terapevticheskiy arhiv. 2007;7:36-43. (In Russ.).
Bondarenko SN, Semenova EV, Vavilov VN. Allogennaya transplantaciya gemopoeticheskih stvolovyh kletok pri ostrom mieloblastnom lejkoze v pervoj remissii. Terapevticheskiy arhiv. 2013;7(85):18-25. (In Russ.).
Bondarenko SN, Moiseev IS, Slesarchuk OA, Darskaya EI, Ekushev KA, Smirnova AG, Alyanskiy AL, Gindina TL, Babenko EV, Kuzmich EV, Semenova EV, Kulagin AD, Zubarovskaya LS, Afanasyev BV. Allogeneic hematopoietic stem cell transplantation in children and adults with acute lymphoblastic leukemia. Cellular Therapy and Transplantation. 2016;2(5):12-20.
Rogacheva YuA, Popova MO, Markova IV. Invazivnye mikozy, obuslovlennye redkimi vozbuditelyami, u detej so zlokachestvennymi opuholyami i nezlokachestvennymi zabolevaniyami krovetvornoj i limfaticheskoj tkani na fone transplantacii kostnogo mozga i protivoopuholevoj himioterapii. Pediatriya. Zhurnal im. G.N. Speranskogo. 2019;1(98):28-35. (In Russ.). https://doi.org/10.24110/0031-403X-2019-98-1-28-35
Hammond SP, Baden LR, Marty FM. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Antimicrob Agents Chemother. 2011;55(11):5018-5021. Epub 2011 Aug 29. PMID: 21876046; PMCID: PMC3195043. https://doi.org/10.1128/AAC.00536-11
Zilberberg MD, Shorr AF, Huang H, Chaudhari P, Paly VF, Menzin J. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis. 2014;14:310. PMID: 24903188; PMCID: PMC4061526. https://doi.org/10.1186/1471-2334-14-310
Klimko N, Kozlova Y, Khostelidi S, Shadrivova O, Borzova Y, Burygina E, Vasilieva N, Denning DW. The burden of serious fungal diseases in Russia. Mycoses. 2015;58(suppl 5):58-62. PMID: 26449508. https://doi.org/10.1111/myc.12388
Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C, Herbrecht R. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102(3):433-444. Epub 2016 Dec 23. PMID: 28011902; PMCID: PMC5394968. https://doi.org/10.3324/haematol.2016.152900
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):405-421. Epub 2019 Nov 5. PMID: 31699664; PMCID: PMC8559573. https://doi.org/10.1016/S1473-3099(19)30312-3